Plasma selenoprotein P concentration and lung cancer risk: results from a case–control study nested within the Shanghai Men’s Health Study
- 4 August 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 39 (11) , 1352-1358
Abstract
Selenoprotein P (SELENOP) is a major selenoenzyme in plasma and linked to antioxidant properties and possibly to lung cancer; however, supporting evidence is limited. We investigated the association between pre-diagnostic plasma SELENOP concentration and lung cancer risk in a case–control study of 403 cases and 403 individually matched controls nested within the Shanghai Men’s Health Study. SELENOP concentration in pre-diagnostic plasma samples was measured by a sandwich enzyme-linked immunosorbent assay. Cases were diagnosed with lung cancer between 2003 and 2010. Multivariate conditional logistic regression was used to estimate odds ratios (OR) and the corresponding 95% confidence intervals (CI) for studying the association between plasma SELENOP concentration and lung cancer risk. Cases had slightly lower plasma SELENOP concentration than controls (4.3 ± 1.2 versus 4.4 ± 1.1 mg/l, P difference = 0.09). However, the multivariate analysis showed no association between plasma SELENOP concentration and lung cancer risk among all participants (OR = 1.08, 95% CI = 0.54–2.14 for quartile 4 versus quartile 1), or by smoking status or tumor aggressiveness. In contrast, although the number of cases was limited, plasma SELENOP concentration was positively associated with lung adenocarcinoma risk (OR = 5.38, 95% CI = 1.89–15.35 for tertile 3 versus tertile 1), but not with squamous cell lung carcinoma (OR = 1.69, 95% CI = 0.43–6.70). Our study of adult men living in selenium non-deficient areas in China provides little support for the inverse association between pre-diagnostic plasma SELENOP concentration and lung cancer risk. Our finding of a positive association with risk of lung adenocarcinoma needs to be interpreted with caution.Keywords
Funding Information
- National Cancer Institute (UM1 CA173640, R01 CA082729)
- National Institute of Environmental Health Sciences (R37 ES002497)
This publication has 33 references indexed in Scilit:
- A Low Selenium Level Is Associated with Lung and Laryngeal CancersPLOS ONE, 2013
- Selenium, Selenoenzymes, Oxidative Stress and Risk of Neoplastic Progression from Barrett's Esophagus: Results from Biomarkers and Genetic VariantsPLOS ONE, 2012
- Determinants of selenium status in healthy adultsNutrition Journal, 2011
- Lung Cancer Risk Among Smokers of Menthol CigarettesJNCI: Journal of the National Cancer Institute, 2011
- Selenoprotein P—Expression, functions, and roles in mammalsBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Expression of selenoprotein-coding genes SEPP1, SEP15 and hGPX1 in non-small cell lung cancerLung Cancer, 2009
- Methods of assessment of selenium status in humans: a systematic reviewThe American Journal of Clinical Nutrition, 2009
- Serum selenium and selenoprotein P status in adult Danes – 8-year followupJournal of Trace Elements in Medicine and Biology, 2009
- Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other CancersJAMA, 2009
- Food-chain selenium and human health: emphasis on intakeBritish Journal of Nutrition, 2008